Karen Marie Hagen

Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome

Astrid Olsnes Kittang, Shahram Kordasti, Kristoffer Sand et al. · OncoImmunology · 2015 · 134 citations · Full text

Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells

Ina Nepstad, Kimberley Joanne Hatfield, Ida Sofie Grønningsæter et al. · Signal Transduction and Targeted Therapy · 2019 · 71 citations · Full text

The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cells

Håkon Reikvam, Annette K. Brenner, Karen Marie Hagen et al. · Stem Cell Research · 2015 · 59 citations · Full text

Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism

Annette K. Brenner, Tor Henrik Anderson Tvedt, Ina Nepstad et al. · Expert Opinion on Therapeutic Targets · 2017 · 27 citations

CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia

Audrey Astori, Hanne Fredly, Thomas A. Aloysius et al. · Oncotarget · 2013 · 22 citations · Full text